High simian T-cell leukemia virus type 1 proviral loads combined with genetic stability as a result of cell-associated provirus replication in naturally infected, asymptomatic monkeys
Anne-Sophie Gabet
Unité d'Oncogenèse Virale, Centre Léon Bérard, Lyon, France
Search for more papers by this authorAntoine Gessain
Unité d'Epidémiologie et Physiopathologie des Virus Oncogènes, Institut Pasteur, Paris, France
Search for more papers by this authorCorresponding Author
Eric Wattel
Unité d'Oncogenèse Virale, Centre Léon Bérard, Lyon, France
Service d'Hématologie, Pavillon E, Hôpital Edouard Herriot, Lyon, France
Fax: +33-4-78-78-27-17
Unité d'Oncogenèse Virale, UMR5537-CNRS-Université Claude Bernard, Centre Léon Bérard, 28, rue Laënnec 69373 Lyon Cedex 08 FranceSearch for more papers by this authorAnne-Sophie Gabet
Unité d'Oncogenèse Virale, Centre Léon Bérard, Lyon, France
Search for more papers by this authorAntoine Gessain
Unité d'Epidémiologie et Physiopathologie des Virus Oncogènes, Institut Pasteur, Paris, France
Search for more papers by this authorCorresponding Author
Eric Wattel
Unité d'Oncogenèse Virale, Centre Léon Bérard, Lyon, France
Service d'Hématologie, Pavillon E, Hôpital Edouard Herriot, Lyon, France
Fax: +33-4-78-78-27-17
Unité d'Oncogenèse Virale, UMR5537-CNRS-Université Claude Bernard, Centre Léon Bérard, 28, rue Laënnec 69373 Lyon Cedex 08 FranceSearch for more papers by this authorAbstract
Simian T-cell leukemia virus type 1 (STLV-1) is a primate T cell leukemia virus of the group of oncogenic delta retroviruses. Sharing a high level of genetic homology with human T cell leukemia virus type 1 (HTLV-1), it is etiologically linked to the development of simian T cell malignancies that closely resemble HTLV-1 associated leukemias and lymphomas and might thus constitute an interesting model of study. The precise nature of STLV-1 replication in vivo remains unknown. The STLV-1 circulating proviral load of 14 naturally infected Celebes macaques (Macaca tonkeana) was measured by real-time quantitative PCR. The mean proportion of infected peripheral mononuclear cells was 7.9%, ranging from <0.4% to 38.9%. Values and distributions were closely reminiscent of those observed in symptomatic and asymptomatic HTLV-1 infected humans. Sequencing more than 32 kb of LTRs deriving from 2 animals with high proviral load showed an extremely low STLV-1 genetic variability (0.113%). This paradoxical combination of elevated proviral load and remarkable genetic stability was finally explained by the demonstration of a cell-associated dissemination of the virus in vivo. Inverse PCR (IPCR) amplification of STLV-1 integration sites evidenced clones of infected cells in all infected animals. The pattern of STLV-1 replication in these asymptomatic monkeys was indistinguishable from that of HTLV-1 in asymptomatic carriers or in patients with inflammatory diseases. We conclude that, as HTLV-1, STLV-1 mainly replicates by the clonal expansion of infected cells; accordingly, STLV-1 natural monkey infection constitutes an appropriate and promising model for the study of HTLV-1 associated leukemogenesis in vivo. © 2003 Wiley-Liss, Inc.
REFERENCES
- 1 Miyoshi I, Ohtsuki Y, Fujishita M, Yoshimoto S, Kubonishi I, Minezawa M. Detection of type C virus particles in Japanese monkeys seropositive to adult T cell leukemia-associated antigens. Gann 1982; 73: 848–9.
- 2 Becker WB, Becker ML, Homma T, Brede HD, Kurth R. Serum antibodies to human T-cell leukaemia virus type I in different ethnic groups and in non-human primates in South Africa. S Afr Med J 1985; 67: 445–9.
- 3 Botha MC, Jones M, de Klerk WA, Yamamoto N. Spread and distribution of human T-cell leukaemia virus type I-reactive antibody among baboons and monkeys in the northern and eastern Transvaal. S Afr Med J 1985; 67: 665–8.
- 4 Coursaget P, Barres JL, Yvonnet B, Chiron JP, Cornet M, Ferrara L, et al. Antibodies to human T-cell leukemia virus (HTLV-1) in non human primates from Senegal. Biomed Pharmacother 1985; 39: 198–9.
- 5 Daniel MD, Letvin NL, Sehgal PK, Schmidt DK, Silva DP, Solomon KR, et al. Prevalence of antibodies to 3 retroviruses in a captive colony of macaque monkeys. Int J Cancer 1988; 41: 601–8.
- 6 Dracopoli NC, Turner TR, Else JG, Jolly CJ, Anthony R, Gallo RC, et al. 1986. STLV-I antibodies in feral populations of East African vervet monkeys (Cercopithecus aethiops). Int J Cancer 1986; 38: 523–9.
- 7 Estaquier J, Peeters M, Bedjabaga L, Honore C, Bussi P, Dixson A, Delaporte E. Prevalence and transmission of simian immunodeficiency virus and simian T-cell leukemia virus in a semi-free-range breeding colony of mandrills in Gabon. Aids 1991; 5: 1385–6.
- 8 Fultz PN, Gordon TP, Anderson DC, McClure HM. Prevalence of natural infection with simian immunodeficiency virus and simian T-cell leukemia virus type I in a breeding colony of sooty mangabey monkeys. Aids 1990; 4: 619–25.
- 9 Guo HG, Wong-Stall F, Gallo RC. Novel viral sequences related to human T-cell leukemia virus in T cells of a seropositive baboon. Science 1984; 223: 1195–7.
- 10 Hayami M, Komuro A, Nozawa K, Shotake T, Ishikawa K, Yamamoto K, et al. Prevalence of antibody to adult T-cell leukemia virus-associated antigens (ATLA) in Japanese monkeys and other non-human primates. Int J Cancer 1984; 33: 179–83.
- 11 Hunsmann G, Schneider J, Schmitt J, Yamamoto N. Detection of serum antibodies to adult T-cell leukemia virus in non-human primates and in people from Africa. Int J Cancer 1983; 32: 329–32.
- 12 Ibrahim F, de The G, Gessain A. Isolation and characterization of a new simian T-cell leukemia virus type 1 from naturally infected Celebes macaques (Macaca tonkeana): complete nucleotide sequence and phylogenetic relationship with the Australo-Melanesian human T-cell leukemia virus type 1. J Virol 1995; 69: 6980–93.
- 13 Ishida T, Yamamoto K, Kaneko R, Tokita E, Hinuma Y. Seroepidemiological study of antibodies to adult T-cell leukemia virus-associated antigen (ATLA) in free-ranging Japanese monkeys (Macaca fuscata). Microbiol Immunol 1983; 27: 297–301.
- 14 Ishikawa K, Fukasawa M, Tsujimoto H, Else JG, Isahakia M, Ubhi NK, Ishida T, Takenaka O, Kawamoto Y, Shotake T, Oshawa H, Ivanoff B, et al. Serological survey and virus isolation of simian T-cell leukemia/T-lymphotropic virus type I (STLV-I) in non-human primates in their native countries. Int J Cancer 1987; 40: 233–9.
- 15 Komuro A, Watanabe T, Miyoshi I, Hayami M, Tsujimoto H, Seiki M, Yoshida M. Detection and characterization of simian retroviruses homologous to human T-cell leukemia virus type I. Virology 1984; 138: 373–8.
- 16 Lee RV, Prowten AW, Satchidanand SK, Srivastava BI. Non-Hodgkin's lymphoma and HTLV-1 antibodies in a gorilla. N Engl J Med 1985; 312: 118–9.
- 17 Lowenstine LJ, Pedersen NC, Higgins J, Pallis KC, Uyeda A, Marx P, Lerche NW, Munn RJ, Gardner MB. Seroepidemiologic survey of captive Old-World primates for antibodies to human and simian retroviruses, and isolation of a lentivirus from sooty mangabeys (Cercocebus atys). Int J Cancer 1986; 38: 563–74.
- 18 Miyoshi I, Fujishita M, Taguchi H, Matsubayashi K, Miwa N, Tanioka Y. Natural infection in non-human primates with adult T-cell leukemia virus or a closely related agent. Int J Cancer 1983; 32: 333–6.
- 19 Miyoshi I, Fujishita M, Taguchi H, Matsubayashi K, Miwa N, Tanioka Y. Horizontal transmission of adult T-cell leukaemia virus from male to female Japanese monkey. Lancet 1983; 1: 241.
- 20 Miyoshi I, Fujishita M, Taguchi H, Niiya K, Kobayashi M, Matsubayashi K, Miwa N. Natural adult T-cell leukemia virus infection in Japanese monkeys. Lancet 1982; 2: 658.
- 21 Saksena NK, Herve V, Durand JP, Leguenno B, Diop OM, Digouette JP, Mathiot C, Muller MC, Love JL, Dube S, Benz PM, Erensoy S, et al. Seroepidemiologic, molecular, and phylogenetic analyses of simian T-cell leukemia viruses (STLV-I) from various naturally infected monkey species from central and western Africa. Virology 1994; 198: 297–310.
- 22 Tsujimoto H, Seiki M, Nakamura H, Watanabe T, Sakakibara I, Sasagawa A, Honjo S, Hayami M, Yoshida M. Adult T-cell leukemia-like disease in monkey naturally infected with simian retrovirus related to human T-cell leukemia virus type I. Jpn J Cancer Res 1985; 76: 911–4.
- 23 Voevodin AF, Lapin BA, Yakovleva LA, Ponomaryeva TI, Oganyan TE, Razmadze EN. Antibodies reacting with human T-lymphotropic retrovirus (HTLV-I) or related antigens in lymphomatous and healthy hamadryas baboons. Int J Cancer 1985; 36: 579–84.
- 24 Watanabe T, Seiki M, Hirayama Y, Yoshida M. Human T-cell leukemia virus type I is a member of the African subtype of simian viruses (STLV). Virology 1986; 148: 385–8.
- 25 Ferrer JF, Abt DA, Bhatt DM, Marshak RR. Studies on the relationship between infection with bovine C-type virus, leukemia, and persistent lymphocytosis in cattle. Cancer Res 1974; 34: 893–900.
- 26 Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980; 77: 7415–21.
- 27 Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Golde D, Gallo RC. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1982; 218: 571–3.
- 28 Van Dooren S, Salemi M, Pourrut X, Peeters M, Delaporte E, Van Ranst M, et al. Evidence for a second simian T-cell lymphotropic virus type 3 in Cercopithecus nictitans from Cameroon. J Virol 2001; 75: 11939–41.
- 29 Meertens L, Mahieux R, Mauclere P, Lewis J, Gessain A. Complete sequence of a novel highly divergent simian T-cell lymphotropic virus from wild-caught red-capped mangabeys (Cercocebus torquatus) from Cameroon: a new primate T-lymphotropic virus type 3 subtype. J Virol 2002; 76: 259–68.
- 30 Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2: 407–10.
- 31 Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984–87). Br J Haematol 1991; 79: 428–37.
- 32 Takatsuki K, Yamaguchi K, Kawano F, Hattori T, Nishimura H, Tsuda H, Sanada I, Nakada K, Itai Y. Clinical diversity in adult T-cell leukemia-lymphoma. Cancer Res 1985; 45( Suppl): 4644s–45s.
- 33 Voevodin A, Samilchuk E, Schatzl H, Boeri E, Franchini G. Interspecies transmission of macaque simian T-cell leukemia/lymphoma virus type 1 in baboons resulted in an outbreak of malignant lymphoma. J Virol 1996; 70: 1633–9.
- 34 Hubbard GB, Mone JP, Allan JS, Davis KJ 3rd, Leland MM, Banks PM, Smir B. Spontaneously generated non-Hodgkin's lymphoma in twenty-seven simian T-cell leukemia virus type 1 antibody-positive baboons (Papio species). Lab Anim Sci 1993; 43: 301–9.
- 35 McCarthy TJ, Kennedy JL, Blakeslee JR, Bennett BT. Spontaneous malignant lymphoma and leukemia in a simian T-lymphotropic virus type I (STLV-I) antibody positive olive baboon. Lab Anim Sci 1990; 40: 79–81.
- 36 Traina-Dorge V, Blanchard J, Martin L, Murphey-Corb M. 1992. Immunodeficiency and lymphoproliferative disease in an African green monkey dually infected with SIV and STLV-I. AIDS Res Hum Retroviruses 1992; 8: 97–100.
- 37 Tsujimoto H, Noda Y, Ishikawa K, Nakamura H, Fukasawa M, Sakakibara I, Sasagawa A, Honjo S, Hayami M. Development of adult T-cell leukemia-like disease in African green monkey associated with clonal integration of simian T-cell leukemia virus type I. Cancer Res 1987; 47: 269–74.
- 38 Sakakibara I, Sugimoto Y, Sasagawa A, Honjo S, Tsujimoto H, Nakamura H, Hayami M. 1986. Spontaneous malignant lymphoma in an African green monkey naturally infected with simian T-lymphotropic virus (STLV). J Med Primatol 1986; 15: 311–8.
- 39 Jayo MJ, Laber-Laird K, Bullock BC, Tulli HM, Reynolds GM. T-cell lymphosarcoma in a female African green monkey (Cercopithecus aethiops). Lab Anim Sci 1990; 40: 37–41.
- 40 Homma T, Kanki PJ, King NW Jr., Hunt RD, O'Connell MJ, Letvin NL, Daniel MD, Desrosiers RC, Yang CS, Essex M. Lymphoma in macaques: association with virus of human T lymphotrophic family. Science 1984; 225: 716–8.
- 41 Srivastava BI, Wong-Staal F, Getchell JP. Human T-cell leukemia virus I provirus and antibodies in a captive gorilla with non-Hodgkin's lymphoma. Cancer Res 1986; 46: 4756–8.
- 42 Blattner WA. Human T-lymphotrophic viruses and diseases of long latency. Ann Intern Med 1989; 111: 4–6.
- 43 Slattery JP, Franchini G, Gessain A. Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T-cell leukemia/lymphotropic viruses. Genome Res 1999; 9: 525–40.
- 44 Komurian F, Pelloquin F, de The G. In vivo genomic variability of human T-cell leukemia virus type I depends more upon geography than upon pathologies. J Virol 1991; 65: 3770–8.
- 45 Paine E, Garcia J, Philpott TC, Shaw G, Ratner L. Limited sequence variation in human T-lymphotropic virus type 1 isolates from North American and African patients. Virology 1991; 182: 111–23.
- 46 Ratner L, Philpott T, Trowbridge DB. Nucleotide sequence analysis of isolates of human T-lymphotropic virus type 1 of diverse geographical origins. AIDS Res Hum Retroviruses 1991; 7: 923–41.
- 47 Schulz TF, Calabro ML, Hoad JG, Carrington CV, Matutes E, Catovsky D, Weiss RA. HTLV-1 envelope sequences from Brazil, the Caribbean, and Romania: clustering of sequences according to geographic origin and variability in an antibody epitope. Virology 1991; 184: 483–91.
- 48 Sherman MP, Saksena NK, Dube DK, Yanagihara R, Poiesz BJ. Evolutionary insights on the origin of human T-cell lymphoma/leukemia virus type I (HTLV-I) derived from sequence analysis of a new HTLV-I variant from Papua New Guinea. J Virol 1992; 66: 2556–63.
- 49 Mortreux F, Gabet AS, Wattel E. Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo. Leukemia 2003; 17: 26–38.
- 50 Wattel E. Proliferation of HTLV-1 infected cells in vivo: pathogenic implications in leukemogenesis and neuropathogenesis. Arlington, Texas: ABI Professional Publications, 1999.
- 51 Wattel E, Vartanian JP, Pannetier C, Wain-Hobson S. Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J Virol 1995; 69: 2863–668.
- 52 Wattel E, Mariotti M, Agis F, Gordien E, Le Coeur FF, Prin L, Rouger P, Chen IS, Wain-Hobson S, Lefrere JJ. Quantification of HTLV-1 proviral copy number in peripheral blood of symptomless carriers from the French West Indies. J Acquir Immune Defic Syndr 1992; 5: 943–6.
- 53 Gabet AS, Mortreux F, Talarmin A, Plumelle Y, Leclercq I, Leroy A, Gessain A, Clity E, Joubert M, Wattel E. High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis [In Process Citation]. Oncogene 2000; 19: 4954–60.
- 54 Albrecht B, Collins ND, Newbound GC, Ratner L, Lairmore MD. Quantification of human T-cell lymphotropic virus type 1 proviral load by quantitative competitive polymerase chain reaction. J Virol Methods 1998; 75: 123–40.
- 55 Kubota R, Umehara F, Izumo S, Ijichi S, Matsumuro K, Yashiki S, Fujiyoshi T, Sonoda S, Osame M. HTLV-I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy. J Neuroimmunol 1994; 53: 23–9.
- 56 Kira J, Koyanagi Y, Yamada T, Itoyama Y, Goto I, Yamamoto N, Sasaki H, Sakaki Y. Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study [published erratum appears in Ann Neurol 1991;29:363]. Ann Neurol 1991; 29: 194–201.
- 57 Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham CR, Izumo S, Osame M. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 1998; 4: 586–93.
- 58 Mortreux F, Kazanji M, Gabet AS, de Thoisy B, Wattel E. Two-step nature of human T-cell leukemia virus type 1 replication in experimentally infected squirrel monkeys (Saimiri sciureus) [In Process Citation]. J Virol 2001; 75: 1083–9.
- 59 Cavrois M, Gessain A, Wain-Hobson S, Wattel E. 1996. Proliferation of HTLV-1 infected circulating cells in vivo in all asymptomatic carriers and patients with TSP/HAM. Oncogene 1996; 12: 2419–23.
- 60 Cavrois M, Wain-Hobson S, Gessain A, Plumelle Y, Wattel E. Adult T-cell leukemia/lymphoma on a background of clonally expanding human T-cell leukemia virus type-1-positive cells. Blood 1996; 88: 4646–50.
- 61 Fujii M, Niki T, Mori T, Matsuda T, Matsui M, Nomura N, Seiki M. HTLV-1 Tax induces expression of various immediate early serum responsive genes. Oncogene 1991; 6: 1023–9.
- 62 Inoue J, Seiki M, Taniguchi T, Tsuru S, Yoshida M. Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1. EMBO J 1986; 5: 2883–8.
- 63 Suzuki T, Kitao S, Matsushime H, Yoshida M. HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4. EMBO J 1996; 15: 1607–14.
- 64 Santiago F, Clark E, Chong S, Molina C, Mozafari F, Mahieux R, Fujii M, Azimi N, Kashanchi F. Transcriptional up-regulation of the cyclin D2 gene and acquisition of new cyclin-dependent kinase partners in human T-cell leukemia virus type 1-infected cells. J Virol 1999; 73: 9917–27.
- 65 Neuveut C, Low KG, Maldarelli F, Schmitt I, Majone F, Grassmann R, Jeang KT. Human T-cell leukemia virus type 1 Tax and cell cycle progression: role of cyclin D-cdk and p110Rb. Mol Cell Biol 1998; 18: 3620–32.
- 66 Haller K, Wu Y, Derow E, Schmitt I, Jeang KT, Grassmann R. Physical interaction of human T-cell leukemia virus type 1 Tax with cyclin-dependent kinase 4 stimulates the phosphorylation of retinoblastoma protein. Mol Cell Biol 2002; 22: 3327–38.
- 67 Mortreux F, Leclercq I, Gabet A, Leroy A, Westhof E, Gessain A, Wain-Hobson S, Wattel E. Somatic mutation in human T-Cell leukemia virus type 1 provirus and flanking cellular sequences during clonal expansion in vivo. J Natl Cancer Inst 2001; 93: 367–77.
- 68 Hanon E, Hall S, Taylor GP, Saito M, Davis R, Tanaka Y, Usuku K, Osame M, Weber JN, Bangham CR. Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 2000; 95: 1386–92.
- 69 Jeang KT, Widen SG, Semmes OT, Wilson SH. HTLV-I trans-activator protein, Tax, is a trans-repressor of the human beta-polymerase gene. Science 1990; 247: 1082–84.
- 70 Kao SY, Marriott SJ. Disruption of nucleotide excision repair by the human T-cell leukemia virus type 1 Tax protein. J Virol 1999; 73: 4299–304.
- 71 Philpott SM, Buehring GC. Defective DNA repair in cells with human T-cell leukemia/bovine leukemia viruses: role of tax gene. J Natl Cancer Inst 1999; 91: 933–42.
- 72 Van PL, Yim KW, Jin DY, Dapolito G, Kurimasa A, Jeang KT. Genetic evidence of a role for ATM in functional interaction between human T-cell leukemia virus type 1 Tax and p53. J Virol 2001; 75: 396–407.
- 73 PiseMasison CA, Choi KS, Radonovich M, Dittmer J, Kim SJ, Brady JN. Inhibition of p53 transactivation function by the human T-cell lymphotropic virus type 1 Tax protein. J Virol 1998; 72: 1165–70.
- 74 Jin DY, Spencer F, Jeang KT. Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell 1998; 93: 81–91.
- 75 Miyake H, Suzuki T, Hirai H, Yoshida M. Trans-activator Tax of human T-cell leukemia virus type 1 enhances mutation frequency of the cellular genome. Virology 1999; 253: 155–61.
- 76 Cavrois M, Leclercq I, Gout O, Gessain A, Wain-Hobson S, Wattel E. Persistent oligoclonal expansion of human T-cell leukemia virus type 1-infected circulating cells in patients with Tropical spastic paraparesis/HTLV-1 associated myelopathy. Oncogene 1998; 17: 77–82.
- 77 Leclercq I, Cavrois M, Mortreux F, Hermine O, Gessain A, Morschhauser F, Wattel E. Oligoclonal proliferation of human T-cell leukaemia virus type 1 bearing T cells in adult T-cell leukaemia/lymphoma without deletion of the 3′ provirus integration sites. Br J Haematol 1998; 101: 500–6.
- 78 Agape P, Copin MC, Cavrois M, Panelatti G, Plumelle Y, Ossondo-Landeau M, Quist D, Grossat N, Gosselin B, Fenaux P, Wattel E. 1999. Implication of HTLV-I infection, strongyloidiasis, and P53 overexpression in the development, response to treatment, and evolution of non-Hodgkin's lymphomas in an endemic area (Martinique, French West Indies). J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20: 394–402.
- 79 Leclercq I, Mortreux F, Morschhauser F, Duthilleul P, Desgranges C, Gessain A, Cavrois M, Vernant JP, Hermine O, Wattel E. Semiquantitative analysis of residual disease in patients treated for adult T-cell leukaemia/lymphoma (ATLL). Br J Haematol 1999; 105: 743–51.
- 80 Cavrois M, Gessain A, Gout O, Wain-Hobson S, Wattel E. Common human T-cell leukemia virus type 1 (HTLV-1) integration sites in cerebrospinal fluid and blood lymphocytes of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis indicate that HTLV-1 crosses the blood-brain barrier via clonal HTLV-1-infected cells. J Infect Dis 2000; 182: 1044–50.
- 81 Hadlock KG, Lipka JJ, Chow TP, Foung SK, Reyes GR. Cloning and analysis of a recombinant antigen containing an epitope specific for human T-cell lymphotropic virus type II. Blood 1992; 79: 2789–96.
- 82 Buckner C, Roberts CR, Foung SK, Lipka J, Reyes GR, Hadlock K, Chan L, Gongora-Biachi RA, Hjelle B, Lal RB. Immune responsiveness to the immunodominant recombinant envelope epitopes of human T lymphotropic virus types I and II in diverse geographic populations. J Infect Dis 1992; 166: 1160–3.
- 83 Mahieux R, Pecon-Slattery J, Chen GM, Gessain A. Evolutionary inferences of novel simian T lymphotropic virus type 1 from wild-caught chacma (Papio ursinus) and olive baboons (Papio anubis). Virology 1998; 251: 71–84.
- 84 Meertens L, Rigoulet J, Mauclere P, Van Beveren M, Chen GM, Diop O, Dubreuil G, Georges-Goubot MC, Berthier JL, Lewis J, Gessain A. Molecular and phylogenetic analyses of 16 novel simian T cell leukemia virus type 1 from Africa: close relationship of STLV-1 from Allenopithecus nigroviridis to HTLV-1 subtype B strains. Virology 2001; 287: 275–85.
- 85 Combet C, Blanchet C, Geourjon C, Deleage G. NPS@: network protein sequence analysis. Trends Biochem Sci 2000; 25: 147–50.
- 86 Corpet F. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res 1988; 16: 10881–90.
- 87 Minghetti PP, Ruffner DE, Kuang WJ, Dennison OE, Hawkins JW, Beattie WG, Dugaiczyk A. Molecular structure of the human albumin gene is revealed by nucleotide sequence within q11-22 of chromosome 4. J Biol Chem 1986; 261: 6747–57.
- 88 Cavrois M, Wain-Hobson S, Wattel E. 1995. Stochastic events in the amplification of HTLV-I integration sites by linker-mediated PCR. Res Virol 1995; 146: 179–1784.
- 89 Ohshima K, Kikuchi M, Masuda Y, Kobari S, Sumiyoshi Y, Eguchi F, Mohtai H, Yoshida T, Takeshita M, Kimura N. Defective provirus form of human T-cell leukemia virus type I in adult T-cell leukemia/lymphoma: clinicopathological features. Cancer Res 1991; 51: 4639–42.
- 90 Shimamoto Y, Suga K, Shibata K, Matsuzaki M, Yano H, Yamaguchi M. Clinical importance of extraordinary integration patterns of human T-cell lymphotropic virus type I proviral DNA in adult T-cell leukemia/lymphoma. Blood 1994; 84: 853–8.
- 91 Tamiya S, Matsuoka M, Etoh K, Watanabe T, Kamihira S, Yamaguchi K, Takatsuki K. Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia. Blood 1996; 88: 3065–73.
- 92 Tsukasaki K, Tsushima H, Yamamura M, Hata T, Murata K, Maeda T, Atogami S, Sohda H, Momita S, Ideda S, Katamine S, Yamada Y, et al. Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease. Blood 1997; 89: 948–56.
- 93 Wattel E, Cavrois M, Gessain A, Wain-Hobson S. Clonal expansion of infected cells: a way of life for HTLV-1. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13( Suppl): 92–99.
- 94 Mansky LM. In vivo analysis of human T-cell leukemia virus type 1 reverse transcription accuracy. J Virol 2000; 74: 9525–31.
- 95 Mansky LM. Sorting out mutations in human T-cell leukemia virus type 1 proviruses during in vivo clonal expansion. J Natl Cancer Inst 2001; 93: 336–7.
- 96 Coffin JM. Genetic variation in avian retroviruses. Dev Biol Stand 1990; 72: 123–32.
- 97 Drake JW. A constant rate of spontaneous mutation in DNA-based microbes. Proc Natl Acad Sci USA 1991; 88: 7160–4.
- 98 Beckman RA, Loeb LA. Multi-stage proofreading in DNA replication. Q Rev Biophys 1993; 26: 225–331.
- 99 Akari H, Ono F, Sakakibara I, Takahashi H, Murayama Y, Hiyaoka A, Terao K, Otani I, Mukai R, Adachi A, Yoshikawa Y. Simian T cell leukemia virus type I-induced malignant adult T cell leukemia-like disease in a naturally infected African green monkey: implication of CD8+ T cell leukemia. AIDS Res Hum Retroviruses 1998; 14: 367–71.
- 100 Shinzato O, Ikeda S, Momita S, Nagata Y, Kamihira S, Nakayama E, Shiku H. Semiquantitative analysis of integrated genomes of human T-lymphotropic virus type I in asymptomatic virus carriers. Blood 1991; 78: 2082–88.
- 101 Satoh M, Toma H, Sugahara K, Etoh K, Shiroma Y, Kiyuna S, Takara M, Matsuoka M, Yamaguchi K, Nakada K, Fujita K, Kojima S, et al. Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis. Oncogene 2002; 21: 2466–75.
- 102 Gessain A, Gallo RC, Franchini G. Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations. J Virol 1992; 66: 2288–95.
- 103 Ho DD, Moudgil T, Alam M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 1989; 321: 1621–5.
- 104 Damond F, Descamps D, Farfara I, Telles JN, Puyeo S, Campa P, Lepretre A, Matheron S, Brun-Vezinet F, Simon F. Quantification of proviral load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR. J Clin Microbiol 2001; 39: 4264–8.
- 105 Meyerhans A, Cheynier R, Albert J, Seth M, Kwok S, Sninsky J, Morfeldt-Manson L, Asjo B, Wain-Hobson S. 1989. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 1989; 58: 901–10.
- 106 Pedroza Martins L, Chenciner N, Wain-Hobson S. 1992. Complex intrapatient sequence variation in the V1 and V2 hypervariable regions of the HIV-1 gp 120 envelope sequence. Virology 1992; 191: 837–45.
- 107 Holland JJ, de le Torre JC, Steinhauer DA. RNA virus populations as quasispecies. Curr Top Microbiol Immunol 1992; 176: 1–20.
- 108 Mansky LM, Temin HM. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol 1995; 69: 5087–94.
- 109 Mansky LM, Temin HM. Lower mutation rate of bovine leukemia virus relative to that of spleen necrosis virus. J Virol 1994; 68: 494–99.
- 110 Taguchi H, Sawada T, Fukushima A, Iwata J, Ohtsuki Y, Ueno H, Miyoshi I. Bilateral uveitis in a rabbit experimentally infected with human T-lymphotropic virus type I. Lab Invest 1993; 69: 336–39.
- 111 Ishiguro N, Abe M, Seto K, Sakurai H, Ikeda H, Wakisaka A, Togashi T, Tateno M, Yoshiki T. A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats. J Exp Med 1992; 176: 981–9.
- 112 Yamanouchi K, Kinoshita K, Moriuchi R, Katamine S, Amagasaki T, Ikeda S, Ichimaru M, Miyamoto T, Hino S. Oral transmission of human T-cell leukemia virus type-I into a common marmoset (Callithrix jacchus) as an experimental model for milk-borne transmission. Jpn J Cancer Res 1985; 76: 481–7.
- 113 Ibuki K, Funahashi SI, Yamamoto H, Nakamura M, Igarashi T, Miura T, Ido E, Hayami M, Shida H. Long-term persistence of protective immunity in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the human T cell leukaemia virus type I envelope gene. J Gen Virol 1997; 78: 147–52.
- 114 Kazanji M, Moreau JP, Mahieux R, Bonnemains B, Bomford R, Gessain A, de The G. 1997. HTLV-I infection in squirrel monkeys (Saimiri sciureus) using autologous, homologous, or heterologous HTLV-I-transformed cell lines. Virology 1997; 231: 258–66.
- 115 Kazanji M, Ureta-Vidal A, Ozden S, Tangy F, de Thoisy B, Fiette L, Talarmin A, Gessain A, de The G. Lymphoid organs as a major reservoir for human T-cell leukemia virus type 1 in experimentally infected squirrel monkeys (Saimiri sciureus): provirus expression, persistence, and humoral and cellular immune responses [In Process Citation]. J Virol 2000; 74: 4860–7.
- 116 Kazanji M, Tartaglia J, Franchini G, de Thoisy B, Talarmin A, Contamin H, Gessain A, de The G. Immunogenicity and protective efficacy of recombinant human T-cell leukemia/lymphoma virus type 1 NYVAC and naked DNA vaccine candidates in squirrel monkeys (Saimiri sciureus). J Virol 2001; 75: 5939–48.
- 117 Nakamura H, Tanaka Y, Komuro-Tsujimoto A, Ishikawa K, Takadaya K, Tozawa H, Tsujimoto H, Honjo S, Hayami M. Experimental inoculation of monkeys with autologous lymphoid cell lines immortalized by and producing human T-cell leukemia virus type-I. Int J Cancer 1986; 38: 867–75.
- 118 D'Incan M, Combemale P, Verrier B, Garin D, Audoly G, Brunot J, Desgranges C, Flechaire A. Transient adult T-cell leukemia/lymphoma picture during varicella infection in an HTLV-1 carrier. Leukemia 1994; 8: 682–7.
- 119 Hanabuchi S, Ohashi T, Koya Y, Kato H, Hasegawa A, Takemura F, Masuda T, Kannagi M. Regression of human T-cell leukemia virus type I (HTLV-I)-associated lymphomas in a rat model: peptide-induced T-cell immunity. J Natl Cancer Inst 2001; 93: 1775–83.
- 120 Hanabuchi S, Ohashi T, Koya Y, Kato H, Takemura F, Hirokawa K, Yoshiki T, Yagita H, Okumura K, Kannagi M. Development of human T-Cell leukemia virus type 1-transformed tumors in rats following suppression of T-Cell immunity by CD80 and CD86 Blockade. J Virol 2000; 74: 428–35.
- 121 Jenks PJ, Barrett WY, Raftery MJ, Kelsey SM, van-der-Walt JD, Kon SP, Breur J. Development of human T-cell lymphotropic virus type I-associated adult T-cell leukemia/lymphoma during immunosuppressive treatment following renal transplantation. Clin Infect Dis 1995; 21: 992–3.
- 122 Tsurumi H, Tani K, Tsuruta T, Shirato R, Matsudaira T, Tojo A, Wada C, Uchida H, Ozawa K, Asano S. Adult T-cell leukemia developing during immunosuppressive treatment in a renal transplant recipient. Am J Hematol 1992; 41: 292–4.
- 123 Zanke BW, Rush DN, Jeffery JR, Israels LG. HTLV-1 T cell lymphoma in a cyclosporine-treated renal transplant patient. Transplantation 1989; 48: 695–97.
- 124 Nakada K, Yamaguchi K, Furugen S, Nakasone T, Nakasone K, Oshiro Y, Kohakura M, Hinuma Y, Seiki M, Yoshida M, Matutes E, Catovsky D, et al. Monoclonal integration of HTLV-I proviral DNA in patients with strongyloidiasis. Int J Cancer 1987; 40: 145–48.
- 125 Yamaguchi K, Matutes E, Catovsky D, Galton DA, Nakada K, Takatsuki K. Strongyloides stercoralis as candidate co-factor for HTLV-I-induced leukaemogenesis [letter]. Lancet 1987; 2: 94–5.